4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-008618
CHIEF ACCOUNTING OFFICER acquired 469 shares (grant or award)
- CHIEF ACCOUNTING OFFICER gave up 328 shares (to pay taxes)
- CHIEF ACCOUNTING OFFICER acquired 774 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-01-15 | Grant or award | +469 | $16.00 | $7,504 | 26,997 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-03-16 | Option exercise | +774 | 27,771 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-03-16 | Shares withheld for taxes | −328 | $22.61 | $7,416 | 27,443 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-03-16 | Option exercise · Restricted Share Unit | −774 | 0 | D | ||
Loading xslF345X05/form4-03192025_090332.xml…